These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28405687)

  • 21. GINS2 affects cell proliferation, apoptosis, migration and invasion in thyroid cancer via regulating MAPK signaling pathway.
    He S; Zhang M; Ye Y; Song Y; Ma X; Wang G; Zhuang J; Xia W; Zhao B
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33537829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer.
    Peng L; Song Z; Chen D; Linghu R; Wang Y; Zhang X; Kou X; Yang J; Jiao S
    Biomed Pharmacother; 2016 Dec; 84():1568-1574. PubMed ID: 27829549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GHET1 acts as a prognostic indicator and functions as an oncogenic lncRNA in cervical cancer.
    Zhang Q; Zhang Y; Wang Y
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30948501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
    Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
    Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GINS2 promotes cell proliferation and inhibits cell apoptosis in thyroid cancer by regulating CITED2 and LOXL2.
    Ye Y; Song YN; He SF; Zhuang JH; Wang GY; Xia W
    Cancer Gene Ther; 2019 Mar; 26(3-4):103-113. PubMed ID: 30177819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
    Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
    BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA miR-502-5p inhibits ovarian cancer genesis by downregulation of GINS complex subunit 2.
    Zhan L; Yang J; Liu Y; Cheng Y; Liu H
    Bioengineered; 2021 Dec; 12(1):3336-3347. PubMed ID: 34288816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated Expression Levels of Long Non-Coding RNA, Loc554202, Are Predictive of Poor Prognosis in Cervical Cancer.
    Chen J; Zhu J
    Tohoku J Exp Med; 2017 Nov; 243(3):165-172. PubMed ID: 29129878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
    Li Y; Zhang J; Han S; Qian Q; Chen Q; Liu L; Zhang Y
    Oncol Rep; 2017 Aug; 38(2):1043-1050. PubMed ID: 28627681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients.
    Zheng M; Zhou Y; Yang X; Tang J; Wei D; Zhang Y; Jiang JL; Chen ZN; Zhu P
    Breast Cancer Res Treat; 2014 Nov; 148(2):423-36. PubMed ID: 25348432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients.
    Ye H; Guo X
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31332036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer.
    Liu S; Meng F; Ding J; Ji H; Lin M; Zhu J; Ma R
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30792262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GINS2 promotes the progression of human HNSCC by altering RRM2 expression.
    Wang T; Qian L; Zhang P; Du M; Wu J; Peng F; Yao C; Yin R; Yin L; He X
    Cancer Biomark; 2024; 40(2):171-184. PubMed ID: 38517779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer.
    Zhang X; Li F; Zhu L
    Life Sci; 2018 Sep; 209():242-248. PubMed ID: 30098344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
    Ma J; Yang L; Feng H; Zheng L; Meng H; Li X
    J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition.
    Zhou Y; Huang Y; Cao X; Xu J; Zhang L; Wang J; Huang L; Huang S; Yuan L; Jia W; Yu X; Luo R; Zheng M
    PLoS One; 2016; 11(8):e0160414. PubMed ID: 27513465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling.
    Liu X; Sun L; Zhang S; Zhang S; Li W
    J Cell Physiol; 2020 Nov; 235(11):7747-7756. PubMed ID: 31681988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D; Xu XX; Yan DD; Yuan SH; Lou HM
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.